Convergent evolution of SARS-CoV-2 in human and animals

Hang-Yu Zhou; Cheng-Yang Ji; Hang Fan; Na Han; Xiao-Feng Li; Aiping Wu; Cheng-Feng Qin

doi:10.1007/s13238-021-00847-6

Volume 12 Issue 11

Nov. 2021

Turn off MathJax

Article Contents

Article Navigation > Protein&Cell > 2021 > 12(11): 832-835

Hang-Yu Zhou, Cheng-Yang Ji, Hang Fan, Na Han, Xiao-Feng Li, Aiping Wu, Cheng-Feng Qin. Convergent evolution of SARS-CoV-2 in human and animals[J]. Protein&Cell, 2021, 12(11): 832-835. doi: 10.1007/s13238-021-00847-6

Citation:

Hang-Yu Zhou, Cheng-Yang Ji, Hang Fan, Na Han, Xiao-Feng Li, Aiping Wu, Cheng-Feng Qin. Convergent evolution of SARS-CoV-2 in human and animals[J]. Protein&Cell, 2021, 12(11): 832-835. doi: 10.1007/s13238-021-00847-6

Citation:

PDF( 430 KB)

Convergent evolution of SARS-CoV-2 in human and animals

doi: 10.1007/s13238-021-00847-6

Hang-Yu Zhou^1,2,
Cheng-Yang Ji^1,2,
Hang Fan³,
Na Han^1,2,
Xiao-Feng Li³,
Aiping Wu^{1,2
,
,},
Cheng-Feng Qin^{3
,
,}

1. Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100005, China;
2. Suzhou Institute of Systems Medicine, Suzhou, 215123, China;
3. State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing, 100071, China

Funds:

Aiping Wu was supported by The National Key Plan for Scientific Research and Development of China (2016YFD0500301) and CAMS Initiative for Innovative Medicine (CAMS-I2M, 2016-I2M-1-005), Hang-Yu Zhou was supported by China postdoctoral science foundation grant (2019M660548, 2020T130007ZX) and Youthful Teacher Project of Peking Union Medical College (3332019114). Cheng-Feng Qin was supported by the National Science Fund for Distinguished Young Scholar (No. 81925025), and the Innovative Research Group (No. 81621005) from the NSFC, and the Innovation Fund for Medical Sciences (No.2019RU040) from the Chinese Academy of Medical Sciences (CAMS).

Received Date: 2021-04-06
Publish Date: 2021-11-12

Abstract

FullText(HTML)

References(13)

References

[1]	Cockrell AS, Yount BL, Scobey T, Jensen K, Douglas M, Beall A, Tang X-C, Marasco WA, Heise MT, Baric RS (2016) A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat Microbiol 2:1-11
[2]	Chinese SARS Molecular Epidemiology Consortium (2004) Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303:1666-1669
[3]	Davies NG, Barnard RC, Jarvis CI, Kucharski AJ, Munday J, Pearson CA, Russell TW, Tully DC, Abbott S, Gimma A (2020) Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv.
[4]	Elbe S, Buckland-Merrett G (2017) Data, disease and diplomacy:GISAID's innovative contribution to global health. Glob Chall 1:33-46
[5]	Grubaugh ND, Petrone ME, Holmes EC (2020) We shouldn't worry when a virus mutates during disease outbreaks. Nat Microbiol 5:529-530
[6]	Gu H, Chen Q, Yang G, He L, Fan H, Deng Y-Q, Wang Y, Teng Y, Zhao Z, Cui Y (2020) Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science 369:1603-1607
[7]	Leist SR, Dinnon KH III, Schäfer A, Longping VT, Okuda K, Hou YJ, West A, Edwards CE, Sanders W, Fritch EJ (2020) A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183:1070-1085
[8]	Munnink BBO, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, Van Der Spek A, Tolsma P, Rietveld A, Brouwer M (2020) Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science 371:172-177
[9]	Roberts A, Deming D, Paddock CD, Cheng A, Yount B, Vogel L, Herman BD, Sheahan T, Heise M, Genrich GL (2007) A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 3:e5
[10]	Shu Y, McCauley J (2017) GISAID:global initiative on sharing all influenza data-from vision to reality. Eurosurveillance 22:30494
[11]	Starr TN, Greaney AJ, Hilton SK, Ellis D, Crawford KH, Dingens AS, Navarro MJ, Bowen JE, Tortorici MA, Walls AC (2020) Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182:1295-1310
[12]	Sun S, Gu H, Cao L, Chen Q, Yang G, Li R-T, Fan H, Ye Q, Deng Y-Q, Song X (2020) Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. bioRxiv.
[13]	Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N (2020) Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2(SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv.

Relative Articles(20)

Relative Articles

[1]	Dali Tong, Mei Zhang, Yunru Yang, Han Xia, Haiyang Tong, Huajun Zhang, Weihong Zeng, Muziying Liu, Yan Wu, Huan Ma, Xue Hu, Weiyong Liu, Yuan Cai, Yanfeng Yao, Yichuan Yao, Kunpeng Liu, Shifang Shan, Yajuan Li, Ge Gao, Weiwei Guo, Yun Peng, Shaohong Chen, Juhong Rao, Jiaxuan Zhao, Juan Min, Qingjun Zhu, Yanmin Zheng, Lianxin Liu, Chao Shan, Kai Zhong, Zilong Qiu, Tengchuan Jin, Sandra Chiu, Zhiming Yuan, Tian Xue. Single-dose AAV-based vaccine induces a high level of neutralizing antibodies against SARS-CoV-2 in rhesus macaques. Protein&Cell, 2023, 14(1): 69-73. doi: 10.1093/procel/pwac020
[2]	Le Chang, Lei Zhao, Yan Xiao, Tingting Xu, Lan Chen, Yan Cai, Xiaojing Dong, Conghui Wang, Xia Xiao, Lili Ren, Lunan Wang. Serosurvey for SARS-CoV-2 among blood donors in Wuhan, China from September to December 2019. Protein&Cell, 2023, 14(1): 28-36. doi: 10.1093/procel/pwac013
[3]	Fei Feng, Yunkai Zhu, Yanlong Ma, Yuyan Wang, Yin Yu, Xinran Sun, Yuanlin Song, Zhugui Shao, Xinxin Huang, Ying Liao, Jingyun Ma, Yuping He, Mingyuan Wang, Longhai Tang, Yaowei Huang, Jincun Zhao, Qiang Ding, Youhua Xie, Qiliang Cai, Hui Xiao, Chun Li, Zhenghong Yuan, Rong Zhang. A CRISPR activation screen identifies genes that enhance SARS-CoV-2 infection. Protein&Cell, 2023, 14(1): 64-68. doi: 10.1093/procel/pwac036
[4]	Yi Zang, Mingbo Su, Qingxing Wang, Xi Cheng, Wenru Zhang, Yao Zhao, Tong Chen, Yingyan Jiang, Qiang Shen, Juan Du, Qiuxiang Tan, Peipei Wang, Lixin Gao, Zhenming Jin, Mengmeng Zhang, Cong Li, Ya Zhu, Bo Feng, Bixi Tang, Han Xie, Ming-Wei Wang, Mingyue Zheng, Xiaoyan Pan, Haitao Yang, Yechun Xu, Beili Wu, Leike Zhang, Zihe Rao, Xiuna Yang, Hualiang Jiang, Gengfu Xiao, Qiang Zhao, Jia Li. High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors. Protein&Cell, 2023, 14(1): 17-27. doi: 10.1093/procel/pwac016
[5]	Daming Zuo, Yu Chen, Jian-piaoCai, Hao-Yang Yuan, Jun-Qi Wu, Yue Yin, Jing-Wen Xie, Jing-Min Lin, Jia Luo, Yang Feng, Long-Jiao Ge, Jia Zhou, Ronald J. Quinn, San-Jun Zhao, Xing Tong, Dong-Yan Jin, Shuofeng Yuan, Shao-Xing Dai, Min Xu. A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo. Protein&Cell, 2023, 14(1): 37-50. doi: 10.1093/procel/pwac027
[6]	Simeng Zhao, Fengjiang Liu, Shizhen Qiu, Qiaoshuai Lan, Yiran Wu, Wei Xu, Junzi Ke, Jie Yang, Xiaoyan Liu, Kun Wang, Hangtian Guo, Shuai Xia, Fangfang Zhang, Jiabei Wang, Xiaowen Hu, Lu Lu, Shibo Jiang, Suwen Zhao, Lianxin Liu, Youhua Xie, Xiuna Yang, Haopeng Wang, Guisheng Zhong. A core epitope targeting antibody of SARS-CoV-2. Protein&Cell, 2023, 14(1): 74-78. doi: 10.1093/procel/pwac042
[7]	Yu-Sheng Chen, Shuaiyao Lu, Bing Zhang, Tingfu Du, Wen-Jie Li, Meng Lei, Yanan Zhou, Yong Zhang, Penghui Liu, Yong-Qiao Sun, Yong-Liang Zhao, Ying Yang, Xiaozhong Peng, Yun-Gui Yang. Comprehensive analysis of RNA-seq and whole genome sequencing data reveals no evidence for SARS-CoV-2 integrating into host genome. Protein&Cell, 2022, 13(5): 379-385. doi: 10.1007/s13238-021-00861-8
[8]	Yao Zhao, Chao Fang, Qi Zhang, Ruxue Zhang, Xiangbo Zhao, Yinkai Duan, Haofeng Wang, Yan Zhu, Lu Feng, Jinyi Zhao, Maolin Shao, Xiuna Yang, Leike Zhang, Chao Peng, Kailin Yang, Dawei Ma, Zihe Rao, Haitao Yang. Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332. Protein&Cell, 2022, 13(9): 689-693. doi: 10.1007/s13238-021-00883-2
[9]	Yichen Li, Shuaiyao Lu, Jinge Gu, Wencheng Xia, Shengnan Zhang, Shenqing Zhang, Yan Wang, Chong Zhang, Yunpeng Sun, Jian Lei, Cong Liu, Zhaoming Su, Juntao Yang, Xiaozhong Peng, Dan Li. SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation. Protein&Cell, 2022, 13(8): 602-614. doi: 10.1007/s13238-022-00905-7
[10]	Chun-Chun Gao, Man Li, Wei Deng, Chun-Hui Ma, Yu-Sheng Chen, Yong-Qiao Sun, Tingfu Du, Qian-Lan Liu, Wen-Jie Li, Bing Zhang, Lihong Sun, Si-Meng Liu, Fengli Li, Feifei Qi, Yajin Qu, Xinyang Ge, Jiangning Liu, Peng Wang, Yamei Niu, Zhiyong Liang, Yong-Liang Zhao, Bo Huang, Xiao-Zhong Peng, Ying Yang, Chuan Qin, Wei-Min Tong, Yun-Gui Yang. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques. Protein&Cell, 2022, 13(12): 920-939. doi: 10.1007/s13238-022-00915-5
[11]	Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillete, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, Honglin Li, Ke Xu. Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein&Cell, 2021, 12(1): 76-80. doi: 10.1007/s13238-020-00792-w
[12]	Wanyin Tao, Xiaofang Wang, Guorong Zhang, Meng Guo, Huan Ma, Dan Zhao, Yong Sun, Jun He, Lianxin Liu, Kaiguang Zhang, Yucai Wang, Jianping Weng, Xiaoling Ma, Tengchuan Jin, Shu Zhu. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein&Cell, 2021, 12(3): 230-235. doi: 10.1007/s13238-020-00778-8
[13]	Wenyu Fu, Yujianan Chen, Kaidi Wang, Aubryanna Hettinghouse, Wenhuo Hu, Jing-Quan Wang, Zi-Ning Lei, Zhe-Sheng Chen, Kenneth A. Stapleford, Chuan-ju Liu. Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction. Protein&Cell, 2021, 12(7): 586-591. doi: 10.1007/s13238-020-00803-w
[14]	Dan Zhao, Weifan Xu, Xiaofan Zhang, Xiaoting Wang, Yiyue Ge, Enming Yuan, Yuanpeng Xiong, Shenyang Wu, Shuya Li, Nian Wu, Tingzhong Tian, Xiaolong Feng, Hantao Shu, Peng Lang, Jingxin Li, Fengcai Zhu, Xiaokun Shen, Haitao Li, Pilong Li, Jianyang Zeng. Understanding the phase separation characteristics of nucleocapsid protein provides a new therapeutic opportunity against SARS-CoV-2. Protein&Cell, 2021, 12(9): 734-740. doi: 10.1007/s13238-021-00832-z
[15]	Yao Zhao, Xiaoyu Du, Yinkai Duan, Xiaoyan Pan, Yifang Sun, Tian You, Lin Han, Zhenming Jin, Weijuan Shang, Jing Yu, Hangtian Guo, Qianying Liu, Yan Wu, Chao Peng, Jun Wang, Chenghao Zhu, Xiuna Yang, Kailin Yang, Ying Lei, Luke W. Guddat, Wenqing Xu, Gengfu Xiao, Lei Sun, Leike Zhang, Zihe Rao, Haitao Yang. High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors. Protein&Cell, 2021, 12(11): 876-887. doi: 10.1007/s13238-021-00836-9
[16]	Xingdong Zhou, Hui Wang, Qun Ji, Mingjuan Du, Yuexia Liang, Huanhuan Li, Fan Li, Hang Shang, Xiujuan Zhu, Wei Wang, Lichun Jiang, Alexey V. Stepanov, Tianyu Ma, Nanxin Gong, Xiaodong Jia, Alexander G. Gabibov, Zhiyong Lou, Yinying Lu, Yu Guo, Hongkai Zhang, Xiaoming Yang. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine. Protein&Cell, 2021, 12(10): 818-823. doi: 10.1007/s13238-021-00840-z
[17]	Rongjuan Pei, Jianqi Feng, Yecheng Zhang, Hao Sun, Lian Li, Xuejie Yang, Jiangping He, Shuqi Xiao, Jin Xiong, Ying Lin, Kun Wen, Hongwei Zhou, Jiekai Chen, Zhili Rong, Xinwen Chen. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection. Protein&Cell, 2021, 12(9): 717-733. doi: 10.1007/s13238-020-00811-w
[18]	Rui Xiong, Leike Zhang, Shiliang Li, Yuan Sun, Minyi Ding, Yong Wang, Yongliang Zhao, Yan Wu, Weijuan Shang, Xiaming Jiang, Jiwei Shan, Zihao Shen, Yi Tong, Liuxin Xu, Yu Chen, Yingle Liu, Gang Zou, Dimitri Lavillete, Zhenjiang Zhao, Rui Wang, Lili Zhu, Gengfu Xiao, Ke Lan, Honglin Li, Ke Xu. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein&Cell, 2020, 11(10): 723-739. doi: 10.1007/s13238-020-00768-w
[19]	Jinliang Wang, Lei Shuai, Chong Wang, Renqiang Liu, Xijun He, Xianfeng Zhang, Ziruo Sun, Dan Shan, Jinying Ge, Xijun Wang, Ronghong Hua, Gongxun Zhong, Zhiyuan Wen, Zhigao Bu. Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. Protein&Cell, 2020, 11(10): 776-782. doi: 10.1007/s13238-020-00767-x
[20]	Bing Zhao, Chao Ni, Ran Gao, Yuyan Wang, Li Yang, Jinsong Wei, Ting Lv, Jianqing Liang, Qisheng Zhang, Wei Xu, Youhua Xie, Xiaoyue Wang, Zhenghong Yuan, Junbo Liang, Rong Zhang, Xinhua Lin. Recapitulation of SARS-CoV-2 infection and cholangiocyte damage with human liver ductal organoids. Protein&Cell, 2020, 11(10): 771-775. doi: 10.1007/s13238-020-00718-6